tetano
Editor, Senior Moderator
Trop Biomed
. 2021 Dec 1;38(4):552-560.
doi: 10.47665/tb.38.4.098.
SARS-CoV-2 seroprevalence and antibody trends in vaccinated, multi-ethnic healthcare employees
C C Beh[SUP] 1 [/SUP], N S Zulkufli[SUP] 1 [/SUP], L M Loh[SUP] 1 [/SUP], K W Cheng[SUP] 1 [/SUP], L M Choo[SUP] 1 [/SUP], M W Cheah[SUP] 1 [/SUP], K W Siow[SUP] 1 [/SUP], R Yon[SUP] 1 [/SUP]
Affiliations
Abstract
Understanding of antibody kinetics against SARS-CoV-2 and its vaccines is rapidly evolving. This study aims to (1) determine post-vaccination seroprevalence; (2) compare antibody levels between vaccine types and various clinical/demographic determinants; and (3) determine post-vaccination antibody concentrations against time. This is a retrospective cross-sectional study involving 148 healthcare employees all over Malaysia. IgG Spike (RBD), IgM Spike and IgG Nucleocapsid concentration medians were compared using Mann-Whitney U or Kruskal-Wallis tests. Chi Square and Spearman correlation coefficient tests were performed to identify variables associated with antibody titers. A scatter plot of IgG Spike (RBD) against time from last vaccine dose was also plotted. At 1-month post-vaccination, all employees successfully seroconverted regardless of vaccine type, health status and COVID- 19 history. Comirnaty, convalescent, female or Malay vaccinees had significantly higher IgG Spike (RBD) titers compared to their respective counterparts. No correlation was found between age and IgG Spike (RBD) levels. Concentration of all three antibodies waned with time post-vaccination, with IgM Spike and IgG Nucleocapsid waning faster than IgG Spike (RBD).
. 2021 Dec 1;38(4):552-560.
doi: 10.47665/tb.38.4.098.
SARS-CoV-2 seroprevalence and antibody trends in vaccinated, multi-ethnic healthcare employees
C C Beh[SUP] 1 [/SUP], N S Zulkufli[SUP] 1 [/SUP], L M Loh[SUP] 1 [/SUP], K W Cheng[SUP] 1 [/SUP], L M Choo[SUP] 1 [/SUP], M W Cheah[SUP] 1 [/SUP], K W Siow[SUP] 1 [/SUP], R Yon[SUP] 1 [/SUP]
Affiliations
- PMID: 35001921
- DOI: 10.47665/tb.38.4.098
Abstract
Understanding of antibody kinetics against SARS-CoV-2 and its vaccines is rapidly evolving. This study aims to (1) determine post-vaccination seroprevalence; (2) compare antibody levels between vaccine types and various clinical/demographic determinants; and (3) determine post-vaccination antibody concentrations against time. This is a retrospective cross-sectional study involving 148 healthcare employees all over Malaysia. IgG Spike (RBD), IgM Spike and IgG Nucleocapsid concentration medians were compared using Mann-Whitney U or Kruskal-Wallis tests. Chi Square and Spearman correlation coefficient tests were performed to identify variables associated with antibody titers. A scatter plot of IgG Spike (RBD) against time from last vaccine dose was also plotted. At 1-month post-vaccination, all employees successfully seroconverted regardless of vaccine type, health status and COVID- 19 history. Comirnaty, convalescent, female or Malay vaccinees had significantly higher IgG Spike (RBD) titers compared to their respective counterparts. No correlation was found between age and IgG Spike (RBD) levels. Concentration of all three antibodies waned with time post-vaccination, with IgM Spike and IgG Nucleocapsid waning faster than IgG Spike (RBD).